baber/WOPTO huggingface dataset:
Patent CA-3133196-A1 (CA)
Inventor: NISHIMURA TETSUYA
IPC: F16K31/68
Filed: 2020-03-06
Abstract: Provided is a thermostat device capable of reducing pressure loss in a flow passage by reducing water flow resistance that is applied by a thermo-operation unit or a frame support part housed in a housing. The thermostat device is provided with: a control valve 2c which opens and closes a flow passage in a housing 3 on the basis of expansion/contraction of a thermal expansion body in a thermoelement 2a; a spring member 2d which biases the control valve in a valve-closing direction; and a spring-receiving frame 2g which receives an end part of the spring member. The spring-receiving frame is locked to a frame support part 3i formed in the flow passage of the housing, and thus a thermo-operation unit 2 is incorporated into the housing. On the upstream side of a cooling water flow in the frame support part 3i, a flow adjustment part 3j is disposed which prevents collision of cooling water streams by setting a bypass flow path for the cooling water traveling to the frame support part and the spring-receiving frame.
Patent CA-3135147-A1 (CA)
Inventor: ITO TORU
IPC: G06N99/00
Filed: 2020-03-30
Abstract: [Problem] To provide an information processing device that highly accurately calculates solutions to combinatorial optimization problems, an information processing system, an information processing method, a storage medium and a program. [Solution] This information processing device is provided with: a storage unit configured to store a first variable which is an element of a first vector and a second variable which is an element of a second vector; and a processing circuit configured such that the second variable, weighted by a first coefficient, is multiplied by a time step and added to the corresponding first variable to update the first variable, the first variable is weighted by the time step and a second coefficient and is added to the corresponding second variable, the multiple first variables are used to calculate a problem term and the problem term, multiplied by the time step, is added to the second variable to update the second variable, the time step is updated, and the second coefficient is monotonically increased or monotonically decreased depending on the number of updates.
Patent CA-3137047-A1 (CA)
Title: Method for output layer set for multilayered video stream
Inventor: CHOI BYEONGDOO
IPC: H04N19/30
Filed: 2020-11-09
Abstract: Systems and methods for coding and decoding are provided. A method includes receiving a coded video stream including a parameter set and video data partitioned into a plurality of layers; deriving, based on the parameter set, at least one first syntax element that specifies at least one first layer, from among the plurality of layers, to be outputted in an output layer set, and at least one second syntax element that indicates profile-tier-level information of the output layer set; and decoding, based on information derived from the parameter set, a portion of the video data of the coded video stream that corresponds to the output layer set.
Patent CA-3137203-A1 (CA)
Inventor: SENNIK SUNDEEPAN
IPC: F16L9/14
Filed: 2021-10-29
Abstract: A membrane for installation circumferentially about a pipe includes: (a) a substrate including: (i) a panel having an underside surface on an underside of the substrate for facing the pipe and a topside surface on a topside of the substrate opposite the underside, (ii) a plurality of underside protrusions projecting form the underside surface for supporting the panel radially apart from the pipe; and (iii) a plurality of topside protrusions projecting from the topside surface. The membrane further includes (b) a foam layer extending over the topside of the substrate; and (c) a heat-reflecting layer extending over the foam layer.
Patent CA-3137694-A1 (CA)
Title: Microorganism with enhanced l-histidine production capacity and method for producing histidine by using same
Inventor: HUH LAN
IPC: C12P13/24
Filed: 2020-03-10
Abstract: The present application relates to a microorganism with enhanced L-histidine production capacity and a method for producing histidine by using same.
Patent CA-3138455-A1 (CA)
Inventor: GHIRARDI SIMONE
IPC: B02C18/00
Filed: 2020-05-15
Abstract: L'invention concerne un rotor (11) destiné à un appareil de broyage de déchets (101), comprenant un corps central (13) définissant au moins une aube radiale (15a, 15b), pourvue, au niveau de son extrémité (17a, 17b) distale par rapport à l'axe de rotation ("S") du rotor (11), d'une tête de marteau (19) dans laquelle sont délimitées une première surface d'impact de choc (21) conçue pour fonctionner lorsque le rotor (11) tourne dans un premier sens dans le sens des aiguilles d'une montre ou dans le sens inverse des aiguilles d'une montre, et une seconde surface d'impact en forme de coin (23) conçue pour fonctionner lorsque le rotor (11) tourne dans un second sens inverse au premier sens.
Patent CA-3139622-A1 (CA)
Inventor: VALADE ANNE
IPC: A61K31/4725
Filed: 2020-06-29
Abstract: La présente invention concerne des composés représentés par la formule (I), qui sont des modulateurs allostériques positifs de D1 et sont par conséquent avantageux en tant qu'agents pharmaceutiques pour le traitement de maladies dans lesquelles les récepteurs D1 jouent un rôle.
Patent CA-3142476-A1 (CA)
Inventor: WERNER DAVID R
IPC: A42B3/04
Filed: 2020-06-02
Abstract: L'invention concerne un système d'éclairage auxiliaire pour un casque pouvant fonctionner avec un système d'éclairage d'un véhicule comprenant une lumière de frein de véhicule, constitué d'une partie casque et d'une partie véhicule. La partie casque est constituée d'une unité d'éclairage de casque, d'un microcontrôleur en communication avec la lumière de frein de casque, et d'un émetteur-récepteur de casque en communication avec le microcontrôleur. La partie véhicule est constituée d'un corps de support, d'un émetteur-récepteur de véhicule et d'un accéléromètre relié au corps de support et en communication avec le microcontrôleur. Le microcontrôleur est programmé avec un algorithme de telle sorte que le microcontrôleur reçoive un signal indiquant la position relative de l'accéléromètre, détermine la capacité de performance de l'accéléromètre lors de la détection d'une accélération du véhicule par rapport à la Terre sur la base du signal indiquant la position de l'accéléromètre, et présente une indication de la capacité de performance de l'accéléromètre.
Patent CA-3142768-A1 (CA)
Inventor: KEULER CHAD
IPC: A61L2/10
Filed: 2021-12-17
Abstract: A sanitizing device for de-activating one or more pathogens located on an article. The sanitizing device includes a control unit, a container having an opening and a defined interior space for receiving a selected article. The sanitizing device includes at least one UV light source located within the interior space and a sensor unit located within the interior space in communication with the control unit. The sanitizing device receives the selected article within the interior space, the sensor detects at least one operating condition and communicates the operating condition to the control unit. The control unit selectively powers the UV light source to emit UV light from the UV light source toward the selected article based upon the operating condition.
Patent CA-3143218-A1 (CA)
Inventor: YANG LAN
IPC: A61K39/395
Filed: 2020-06-10
Abstract: L'invention concerne une protéine comprenant un anticorps ou un fragment de liaison à l'antigène et une molécule d'interleukine liée de manière fonctionnelle à l'anticorps ou au fragment de liaison à l'antigène. L'anticorps ou le fragment de liaison à l'antigène se lie spécifiquement à une protéine de point de contrôle immunitaire. La molécule d'interleukine est l'IL-10.
Patent CA-3143362-A1 (CA)
Title: Homomorphic encryption with applications to private information retrieval
Inventor: GENTRY CRAIG BROADWELL
IPC: H04L9/00
Filed: 2020-06-15
Abstract: A request is received for specific information that can be determined using data in a database on a first computer system. Either at least some of the data is encrypted or the request is encrypted. The first computer system does not have a decryption key to decrypt the encrypted data or request. The first computer system peforms compressible HE operations on the data to determine compressed ciphertext(s) that correspond to the specific information. The operations include using a first uncompressed HE scheme and a second compressed HE scheme. The first HE scheme is used on the data to create other multiple ciphertexts and the second HE scheme is used on the other multiple ciphertexts to pack the other multiple ciphertexts into fewer ciphertexts that are compressed. Both the HE schemes use a same secret key. The first computer system sends a response including compressed ciphertext(s) corresponding to the specific information.
Patent CA-3144554-A1 (CA)
Title: Dental flosser with means for adjusting floss tension
Inventor: XU MENG
IPC: A61C15/04
Filed: 2020-08-12
Abstract: A dental flosser is disclosed. The dental flosser comprises a U-shaped portion having a first arm and a second arm spaced apart from each other, a handle portion which extends from the U-shaped portion, a floss strand having a length and a first end and a second end, and a floss strand attachment member. The first end of the floss strand is fastened to the first arm of the U-shaped portion, and the second end of the floss strand is fastened to the floss strand attachment member, and a middle portion of the floss strand is slideably mounted to the second arm of the U-shaped portion. A user can maneuver the floss strand attachment member to increase or decrease or maintain tension of the floss strand.
Patent CA-3145222-A1 (CA)
Title: Methods for diagnosing the effectiveness of anti-tumor treatment
Inventor: WURFEL WOLFGANG
IPC: C12Q1/6886
Filed: 2020-07-06
Abstract: The present invention relates to a method for predicting whether a subject having a tumor responds to a tumor therapy selected from (i) an immunotherapy, (ii) a chemotherapy, (iii) an anti-hormonal therapy, and (iv) an anti-tyrosin kinase therapy, wherein the method comprises (A) determining the level(s) of at least one nucleic acid molecule and/or at least one protein or peptide in a sample obtained from said subject, wherein the at least one nucleic acid molecule is selected from nucleic acid molecules (a) encoding a polypeptide comprising or consisting of the amino acid sequence of any one of SEQ ID NOs 1 to 6, (b) consisting of the nucleotide sequence of any one of SEQ ID NOs 7 to 12, (c) encoding a polypeptide which is at least 85% identical, preferably at least 90% identical, and most preferred at least 95% identical to the amino acid sequence of (a), (d) consisting of a nucleotide sequence which is at least 95% identical, preferably at least 96% identical, and most preferred at least 98% identical to the nucleotide sequence of (b), (e) consisting of a nucleotide sequence which is degenerate with respect to the nucleic acid molecule of (d), (f) consisting of a fragment of the nucleic acid molecule of any one of (a) to (e), said fragment comprising at least 150 nucleotides, preferably at least 300 nucleotides, more preferably at least 450 nucleotides, and most preferably at least 600 nucleotides, and (g) corresponding to the nucleic acid molecule of any one of (a) to (f), wherein T is replaced by U, and wherein the at least one protein or peptide is selected from proteins or peptides being encoded by the nucleic acid molecule of any one of (a) to (g); and (B) comparing the level(s) of (A) with the level(s) of the at least one nucleic acid molecule and/or the at least one protein or peptide in a sample obtained from one or more subjects that responded to one or more of the therapies of (i) to (iii) or a corresponding pre-determined standard, wherein increased level(s) of (A) as compared to the level(s) or pre-determined standard of (B) indicate(s) that the subject will not respond to the tumor therapy and substantially the same or decreased level(s) of (A) as compared to the level(s) of (B) indicate(s) that the subject will respond to the tumor therapy; or (B') comparing the level(s) of (A) with the level(s) of the at least one nucleic acid molecule and/or the at least one protein or peptide in a sample obtained from one or more subjects that did not respond to one or more of the therapies of (i) to (iii) or a corresponding pre-determined standard, wherein decreased level(s) of (A) as compared to the level(s) or pre-determined standard of (B') indicate(s) that the subject will respond to the tumor therapy and substantially the same or increased level(s) of (A) as compared to the level(s) of (B') indicate(s) that the subject will not respond to the tumor therapy.
Patent CA-3145292-A1 (CA)
Title: Apparatuses, methods, and systems for vibratory screening
Inventor: COLGROVE JAMES R
IPC: B07B1/46
Filed: 2020-07-02
Abstract: Disclosed embodiments include a removable support structure (414, 424, 1706, 1902a, 1902b, 2320a, 2320b, 2402, 2502, 2602) for a vibratory screening machine (100). The removable support structure is a single structure including one or more of plastic, metal, and composite materials and may be configured to provide mechanical support to one or more screening assemblies (409, 419, 1702, 1802, 2008, 2206, 2210) of the vibratory screening machine. The removable support structure may further be configured to be removably fastened to the vibratory screening machine. The removable support structure may be a single thermoplastic injection molded piece or may be a single injection molded piece that includes nylon, carbon, and graphite. The removable support structure may have a concave shape that is configured to mechanically support a screening assembly held under compression or may have a convex shape that is configured to mechanically support a screening assembly held under tension. A disclosed wear protective covering (2502), made of a flexible material, provides wear protection to the removable support structure.
Patent CA-3148894-A1 (CA)
Inventor: WARREN JEREMY EARL
IPC: E04F13/18
Filed: 2022-02-15
Abstract: A method and kit for installing siding panels to an exterior surface of a structure. The method and kit are directed to the positioning of a mending plate between the ends of horizontally adjacent siding panels. Lines of an adhesive are applied to the mending and the mending plate is disposed approximately midway between the ends of each of the adjacent first and second siding panels. Pressure is applied to the ends of the siding panels that are disposed over the respective portions of the mending plate thereby uniformly spreading the adhesive across the back surface of the siding panel and the mending plate to enhance the chemical bond of the adhesive once fully cured.
Patent CA-3150194-A1 (CA)
Inventor: KNIGHT TYLER H
IPC: A47L9/30
Filed: 2022-02-25
Abstract: A vacuum accessory tool is provided. The vacuum accessory tool includes a body, a turbine, a generator, and a light source. The body defines a suction inlet, a fluid outlet, and a fluid flow path extending from the suction inlet to the fluid outlet. The turbine is rotatably mounted to the body in fluid communication with the fluid flow path to be rotated by fluid passing through the fluid flow path. The generator is coupled to the turbine such that rotation of the turbine rotates the shaft to generate power. The light source is electrically coupled to the generator and configured to receive the power generated by the generator to power the light source by the fluid passing through the fluid flow path.
Patent CA-3150498-A1 (CA)
Title: Levodopa polymeric conjugates, formulations thereof, and their uses for the treatment of parkinson's disease
Inventor: PATEL DEVEN
IPC: C07C229/00
Filed: 2020-06-28
Abstract: Compounds of formula I: or a pharmaceutically acceptable salt, hydrate, and/or solvate thereof, wherein: R<sub>1</sub> is a pharmaceutically acceptable polymeric moiety comprising a pharmaceutically acceptable polymer chain such that the carbonyl group is linked to R<sub>1</sub> through an ester, amide, carbonate or carbamate bond; R<sub>2</sub> is hydrogen, or-(C=O)Rs wherein R<sub>5</sub> is a C<sub>1-3</sub> straight or branched chain alkyl group; and R<sub>3</sub> and R<sub>4</sub> are independently selected from hydrogen, C<sub>1-3</sub> straight or branched chain alkyl group, or-(C=0)Re wherein R<sub>6</sub> is -(O-CH<sub>2</sub>-CH<sub>2</sub>)<sub>n</sub>-OCH<sub>3</sub> or a C1-3 straight or branched chain alkyl group, and n is 1 to 5. The compositions are useful for the treatment of Parkinson's disease when administered alone or in combination with carbidopa and/or entacapone.
Patent CA-3150923-A1 (CA)
Inventor: GALUSKA ALAN A
IPC: C08L23/06
Filed: 2020-07-24
Abstract: L'invention concerne des procédés de fabrication de matières particulaires polymères hautement réticulées. Les procédés comprennent le positionnement d'un matériau polymère granulaire dans un appareil de réticulation et la réticulation du matériau polymère granulaire avec l'appareil de réticulation pour former un matériau polymère hautement réticulé. Les procédés comprennent également la formation d'une pluralité de granulés de polymère réticulé à partir du matériau polymère hautement réticulé.
Patent CA-3154847-A1 (CA)
Title: System comprising an aerosol provision system and a computer
Inventor: ROSSER NICHOLAS
IPC: A24F40/60
Filed: 2020-10-14
Abstract: A system comprising an aerosol provision system and a computer. The aerosol provision system is configured to generate aerosol from an aerosol-generating material. The computer is configured to obtain user behaviour data relating to an amount of an ingredient delivered from the aerosol-generating material to a user of the aerosol provision system. The computer then determines default user behaviour with respect to the amount of the ingredient to be delivered on the basis of the obtained user behaviour data. The computer then identifies, based on the obtained user behaviour, under what conditions to deliver a notification to the user, the notification informing the user of the user's current behaviour.
Patent CA-3154885-A1 (CA)
Inventor: CROOK SPENCER RONALD
IPC: G01N33/18
Filed: 2020-10-15
Abstract: Des modes de réalisation de la présente invention concernent un système, un procédé, et des capteurs pour la surveillance microbienne en temps réel sur la base de la présence et des concentrations de signaux microbiens, généralement des composés gazeux, qui reflètent la taille de la population microbienne, de la santé microbienne et/ou du niveau d'activité métabolique microbienne dans des environnements aqueux. L'utilisation de la technologie selon l'invention pour fournir une mesure à distance en ligne de signaux microbiens, et de façon importante la détection de changements à l'intérieur, peut être réalisée pour déterminer des conditions de fonctionnement stables et détecter des fluctuations de la qualité de l'eau. La technologie de surveillance par capteur est capable de surveiller la population microbienne native présente dans un environnement aquatique et ne consomme pas de réactifs ni ne nécessite des points d'échantillonnage discrets. En outre, une mesure en ligne peut être mise en oeuvre pour suivre l'activité microbienne en temps réel.
Patent CA-3155706-A1 (CA)
Inventor: RADTKE IAN
IPC: A01C21/00
Filed: 2016-06-15
Abstract: Systerns, methods and apparatus are provided for applying liquid such as fertilizer during a planting operation. Embodiments include an agricultural device comprising a frame a bracket attached to said frame; and a ground-engaging agricultural component disposed at least partially within a planting trench. The ground-engaging agricultural cornponent is rnounted to said bracket through a. pivot that allows the ground-enga6ng component to pivot side to side along a direction of travel of the agricultural device; wherein said pivot has an axis that descends along the direction of travel of the agricultural device. In sorne embodiments, liquid outlets are rnounted to the ground-engaging component to deposit the liquid into the planting trench.
Patent CA-3157731-A1 (CA)
Inventor: ROMBOUTS FREDERIK JAN RITA
IPC: A61K31/395
Filed: 2020-11-20
Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a subject, pharmaceutical composition comprising such compounds, and their use as MCL-1 inhibitors, useful for treating diseases such as cancer.
Patent CA-3158475-A1 (CA)
Inventor: PAQUIN MICHEL
IPC: B01J43/00
Filed: 2020-10-26
Abstract: In order to reduce the contamination of scandium oxide products, the present disclosure provides a process for removing at least one metal contaminant from a scandium (Sc) concentrate. The process is based on contacting the Sc concentrate with an ion exchange resin to obtain a purified Sc eluate or raffinate. The first ion exchange resin and the second ion exchange resin are strong acid cationic resins with sulfonic acid functional groups in a potassium or sodium form. The purified Sc eluate or raffinate can be used to make scandium oxide products having a reduced amount of metal ion contaminants.
Patent CA-3159437-A1 (CA)
Inventor: SIKORA DEREK
IPC: B64C27/10
Filed: 2020-11-25
Abstract: A bidirectional thrust assembly comprises a motor, a selective power transfer mechanism, and a plurality of fans; wherein a change in direction of rotation of the motor causes the selective power transfer mechanism to change a torque transfer among the plurality of fans, wherein the fans may be opposing, and wherein the fans may be unidirectional. The bidirectional thrust assembly may be used in or by a plurality of craft or with respect to other objects which may need to be maneuvered, included suspended load control systems, vertical takeoff and landing craft, watercraft.
Patent CA-3159894-A1 (CA)
Inventor: LIU JING
IPC: G01N30/32
Filed: 2020-12-15
Abstract: La présente invention concerne une méthode analytique pour séparer et éventuellement quantifier au moins deux tampons ou excipients dans un échantillon en un seul dosage.
Patent CA-3162121-A1 (CA)
Title: Method for treating cancer using artificial adjuvant cells (aavc)
Inventor: OHSUMI KEISUKE
IPC: C12N5/0783
Filed: 2020-12-01
Abstract: Provided is a method for treating or preventing cancer safely and effectively using aAVC. Suitable ranges for the dose of a-GalCer loaded on the surface of aAVC cells preferred from the viewpoint of ensuring safety and efficacy in the treatment and prevention of cancer using aAVC and the amount of a-GalCer loaded on the surface of aAVC cells contained in a pharmaceutical composition containing aAVC were discovered, and, inter alia, a method for treating or preventing cancer safely and effectively using aAVC, aAVC for safe and effective treatment or prevention of cancer, and a pharmaceutical composition containing said aAVC are provided.
Patent CA-3162624-A1 (CA)
Title: Biomarkers for cancer therapy using mdm2 antagonists
Inventor: FERRARI NICOLA
IPC: G01N33/574
Filed: 2020-12-23
Abstract: The invention provides biomarkers to predict effective treatment of cancer using an MDM2 antagonist. Identifying one or more of these biomarkers in a cancer patient allows a determination to be made whether the patient's cancer is likely to be successfully treated using an MDM2 antagonist. Accordingly, the invention relates generally to a companion diagnostic for MDM2 antagonist therapy. The biomarkers are: (i) BAP1; and/or (ii) CDKN2A; and/or (iii) one, two, three, four, five, six, seven, eight, nine, ten or more of: CXCL10, CXCL11, RSAD2, MX1, BATF2, IFI44L, IFITM1, ISG15, CMPK2, IFI27, CD74, IFIH1, CCRL2, IFI44, HERC6, ISG20, IFIT3, HLA-C, OAS1, IFI35, IRF9, EPSTI1, USP18, BST2, CSF1, C1S, DHX58, TRIM14, OASL, IRF7, LGALS3BP, DDX60, LAP3, LAMP3, PARP12, PARP9, SP110, PLSCR1, WARS, STAT1, IRF3, IRF5, MSC, JUN, SPI1, IRF1, COMMD3-BMI1, STAT2, RUNX3, SREBF1, FLI1 and BRCA1.